-+ 0.00%
-+ 0.00%
-+ 0.00%

VAXCYTE DOSES FIRST PARTICIPANTS IN THE OPUS PHASE 3, NONINFERIORITY TRIAL EVALUATING VAX-31 FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE AND PNEUMONIA IN ADULTS

Reuters·12/08/2025 12:00:03

Please log in to view news